| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Nexalin Technology, Inc.: Nexalin's DIFS Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer's and Dementia Across Three Peer-Reviewed Studies | 1 | GlobeNewswire (USA) | ||
| 17.10. | RedChip Companies, Inc.: Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 285 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / October 17, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and BioVie, Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big... ► Artikel lesen | |
| 15.10. | Nexalin Technology stockt ATM-Aktienprogramm auf 10 Millionen US-Dollar auf | 2 | Investing.com Deutsch | ||
| NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 15.10. | Nexalin Technology, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.10. | Nexalin Technology, Inc.: Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer's and Traumatic Brain Injury Programs | 163 | GlobeNewswire (Europe) | HOUSTON, TX, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain... ► Artikel lesen | |
| 10.10. | Nexalin Technology, Inc.: Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit | 3 | GlobeNewswire (USA) | ||
| 08.10. | Why Is Micro-Cap Stock Nexalin Technology Rallying On Wednesday? | 3 | Benzinga.com | ||
| 08.10. | Nexalin stock soars after Alzheimer's treatment shows cognitive benefits | 2 | Investing.com | ||
| 08.10. | Nexalin Technology, Inc.: Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer's Disease with Gen-2 SYNC Neurostimulation Device | 427 | GlobeNewswire (Europe) | 40-Hz DIFS significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial Results published in Radiology, the flagship journal of the Radiological Society of... ► Artikel lesen | |
| 25.09. | Nexalin Technology, Inc.: Nexalin Technology Announces Issuance of U.S. Patent Covering HALO Clarity Device Featuring DIFS Technology | 3 | GlobeNewswire (USA) | ||
| 23.09. | Nexalin Technology, Inc. - 10-K/A, Annual Report | 4 | SEC Filings | ||
| 22.09. | Nexalin Technology, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 19.09. | NSE - Nexalin Technology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 5 | SEC Filings | ||
| 27.08. | Nexalin Technology: EPS übertrifft Schätzungen um 0,04 $ - Umsatz besser als erwartet | 4 | Investing.com Deutsch | ||
| 06.08. | Nexalin Technology, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 01.08. | Nexalin Technology appoints Justin Fleet as CFO | 1 | Seeking Alpha | ||
| 01.08. | Nexalin Technology Appoints Justin Van Fleet As CFO | - | RTTNews | ||
| 01.08. | Nexalin Technology, Inc.: Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives | 260 | GlobeNewswire (Europe) | HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain... ► Artikel lesen | |
| 17.07. | Nexalin Technology: Hauptversammlung wählt Direktoren und erweitert Eigenkapital-Anreizplan | 1 | Investing.com Deutsch | ||
| 17.07. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,000 | +0,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Einer Experteneinschätzung zufolge müsse das deutsche Krankenhaussystem seine... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,530 | +0,34 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,090 | +1,29 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,990 | +1,13 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 29,040 | +3,94 % | KAUFCHANCE!? Gerresheimer Absturz! Renk Korrektur! Nakiki Aktie auf den Bitcoin-Spuren von Strategy und Metaplanet! | Die Nakiki SE elektrisiert mehr und mehr Aktieninvestoren und die Bitcoinwelt. Auf den Spuren von Strategy will man zum ersten deutschen Bitcoin Treasury Unternehmen im regulierten Markt werden. Rund... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,860 | -2,88 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 56,40 Euro belassen. Mit der Reifung des Gesundheitssystems... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,520 | +0,06 % | Jefferies hebt Kursziel für BrightSpring Health wegen starker Fundamentaldaten auf 36 US-Dollar an | ||
| OTTOBOCK | 70,00 | +1,16 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock investiert erneut in NeuroTech-Unternehmen ONWARD Medical | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Ottobock investiert erneut in NeuroTech-Unternehmen ONWARD® Medical... ► Artikel lesen | |
| UNITEDHEALTH | 312,00 | +0,10 % | Nächstes Beben: Molina Healthcare crasht - UnitedHealth schwach | Die US-Krankenversicherer kommen nicht zur Ruhe. Am Mittwochabend hat der Gesundheitsdienstleister Molina Healthcare die Anleger mit enttäuschenden Zahlen erneut verunsichert. Die Aktie brach daraufhin... ► Artikel lesen | |
| GENEDX | 128,87 | +3,08 % | 4 Analysts Assess GeneDx Holdings: What You Need To Know | ||
| ALIGNMENT HEALTHCARE | 17,500 | +1,21 % | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | ||
| ONCOLOGY INSTITUTE | 4,750 | +2,48 % | The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI"), one of the largest value-based oncology groups in the United States, announced today that Dr.... ► Artikel lesen | |
| RXSIGHT | 8,610 | +2,14 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| CLEARPOINT NEURO | 24,740 | -2,14 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| ECKERT & ZIEGLER | 17,550 | -0,62 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen |